A detailed history of Vanguard Group Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 11,436,026 shares of GH stock, worth $310 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,436,026
Previous 11,130,654 2.74%
Holding current value
$310 Million
Previous $301 Million 21.64%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$17.13 - $26.91 $5.23 Million - $8.22 Million
305,372 Added 2.74%
11,436,026 $236 Million
Q4 2023

Feb 14, 2024

BUY
$21.58 - $29.5 $3.89 Million - $5.32 Million
180,424 Added 1.65%
11,130,654 $301 Million
Q3 2023

Nov 14, 2023

BUY
$25.8 - $39.97 $3.79 Million - $5.87 Million
146,902 Added 1.36%
10,950,230 $325 Million
Q2 2023

Aug 14, 2023

BUY
$20.94 - $38.01 $32.9 Million - $59.7 Million
1,569,545 Added 17.0%
10,803,328 $387 Million
Q1 2023

May 15, 2023

BUY
$22.92 - $33.76 $4.44 Million - $6.53 Million
193,543 Added 2.14%
9,233,783 $216 Million
Q4 2022

Feb 10, 2023

BUY
$25.44 - $59.78 $3.17 Million - $7.45 Million
124,674 Added 1.4%
9,040,240 $246 Million
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $3.24 Million - $4.53 Million
74,247 Added 0.84%
8,915,566 $480 Million
Q2 2022

Aug 12, 2022

BUY
$28.82 - $77.35 $2.6 Million - $6.99 Million
90,319 Added 1.03%
8,841,319 $357 Million
Q1 2022

May 13, 2022

SELL
$48.25 - $100.49 $534,899 - $1.11 Million
-11,086 Reduced 0.13%
8,751,000 $580 Million
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $5.07 Million - $6.88 Million
57,156 Added 0.66%
8,762,086 $876 Million
Q3 2021

Nov 12, 2021

BUY
$98.77 - $132.17 $7.65 Million - $10.2 Million
77,430 Added 0.9%
8,704,930 $1.09 Billion
Q2 2021

Aug 13, 2021

BUY
$109.77 - $165.68 $947 Million - $1.43 Billion
8,627,500 New
8,627,500 $1.07 Billion

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.77B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.